About 1,953,825 results (4,451 milliseconds)

'Guarded Enthusiasm' Builds for PCSK9 Inhibitors

http://feedproxy.google.com/~r/Theheartorg/~3/46BAz_lpjJQ/845929
Jun 5, 2015 ... If the patient still does not have their cholesterol level controlled, he will add ezetimibe to the maximally tolerated statin dose. And if the ...

WO2018148417A1 - Triplet combination formulations and methods ...

https://patents.google.com/patent/WO2018148417A1/en
statins are compounds which lower cholesterol levels in the ... In one aspect, the triplet combination does not affect subject heart rate and PR and QRS intervals ...

US10786478B2 - Methods of reducing the risk of cardiovascular ...

https://patents.google.com/patent/US10786478B2/en
In some embodiments, the subject's statin therapy does not include ... The 12-lead ECG parameters included Heart Rate (bpm), PR Interval (msec) ...

US11904017B2 - Methods for reducing or eliminating the need for ...

https://patents.google.com/patent/US11904017B2/en
Lipoprotein apheresis frequency, in the context of the present invention, can ... Heart rate was measured at the time of the measurement of blood pressure.

WO2016149405A1 - Fixed dose combinations comprising etc1002 ...

https://patents.google.com/patent/WO2016149405A1/en
Sep 22, 2016 ... [0008] The general class of“statins” are compounds which lower ... In one aspect, the add-on ETC-1002 therapy does not affect subject heart rate ...

Seeing LDL Cholesterol in a New Light

https://news.google.com/__i/rss/rd/articles/CBMiVWh0dHBzOi8vd3d3Lm1hbmFnZWRoZWFsdGhjYXJlZXhlY3V0aXZlLmNvbS92aWV3L3NlZWluZy1sZGwtY2hvbGVzdGVyb2wtaW4tYS1uZXctbGlnaHTSAQA?oc=5
Nov 11, 2021 ... ... could be taking statins starting at much younger age. Lowering LDL cholesterol, often by taking a statin, has been a tenet of cardiovascular ...

US11116739B2 - Fixed dose combinations and formulations ...

https://patents.google.com/patent/US11116739B2/en
The general class of “statins” are compounds which lower cholesterol levels in the ... does not affect subject heart rate and PR and QRS intervals. In some ...

US10278935B2 - Methods of reducing the risk of a cardiovascular ...

https://patents.google.com/patent/US10278935B2/en
In some embodiments, the method comprises (a) identifying a subject on statin therapy and having a fasting baseline triglyceride level of about 135 mg/dL to ...

US9492545B2 - Compositions of statins and omega-3 fatty acids ...

https://patents.google.com/patent/US9492545B2/en
By “stable” is intended that the solubilized statin does not ... After pH adjustment, the two peaks were shown to reduce to a single peak of intact statin.

CN104042600A - Methods for improving cognitive function and ...

https://patents.google.com/patent/CN104042600A/en
... the heart rate that can reduce treatment target.Therefore, in some embodiments, giving DHA also can be for reducing object heart rate (particularly those ...

US20150160229A1 - Methods for detection of heart failure - Google ...

https://patents.google.com/patent/US20150160229A1/en
... a lower level in this experiment. ... Unfortunately, digitalis does not reduce mortality rates, although it does reduce hospitalizations and worsening of heart ...

US9693984B2 - Methods of reducing the risk of a cardiovascular ...

https://patents.google.com/patent/US9693984B2/en
In some embodiments, the method comprises (a) identifying a subject on statin therapy and having a fasting baseline triglyceride level of about 135 mg/dL to ...

US20210121419A1 - Metformin compounded composition and ...

https://patents.google.com/patent/US20210121419A1/en
The main function of statin is to lower the level of LDL-cholesterol. It has ... can reduce triglycerides, heart rate, blood pressure, and atherosclerosis.

CA2748160A1 - Use of fibrates in the treatment of obstructive sleep ...

https://patents.google.com/patent/CA2748160A1/en
Fibrate compounds can also elevate the level of plasma HDL cholesterol. ... 10 maximum pulse rate, decrease in daytime sleepiness assessed by the ESS ...

NL2024271B1 - Rhodospirillum rubrum cells that lower plasma ...

https://patents.google.com/patent/NL2024271B1/en
This was also observed when atorvastatin was combined with ezetimibe. Statins have also been shown to increase resting heart rate in healthy human subjects; a ...

US9168277B2 - Nutraceutical compositions produced from co ...

https://patents.google.com/patent/US9168277B2/en
“Drying” can optionally be carried out on these products and compositions to reduce the moisture level. Examples of drying processes that can be used include, ...

CN111840524A - Application of nattokinase in treating coronary ...

https://patents.google.com/patent/CN111840524A/en
... statins and antianginal drugs (nitrates, beta ... Beta receptor anticoagulant drugs can reduce the oxygen consumption of patients by reducing heart rate ...

Cardiology 2019: Top Trials in Review

http://feedproxy.google.com/~r/Theheartorg/~3/rzlqsi-U_3Y/922596
Dec 17, 2019 ... ... the trial in anticipation of a lower-than-expected event rate. I ... heart rate did they achieve, what happened to their blood pressure ...